⌘K
Loading ticker…
Boundless Bio, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Boundless Bio, Inc. Common Stock (BOLD) has a 3-month relative strength percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 85. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.1%, relative volume 0.07×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 97, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BOLD is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 63.7% / 97.8%.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
BOLD is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $490K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $490K |
| VXFVanguard Extended Market ETF | 0.00% | $167K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BOLD Jan avg: -12.18% median: -12.18% win: 0% σ: 12.52% n: 2 2024-04-01 → 2026-05-29 | BOLD Feb avg: -7.86% median: -7.86% win: 50% σ: 11.12% n: 2 2024-04-01 → 2026-05-29 | BOLD Mar avg: -13.47% median: -13.47% win: 0% σ: 11.73% n: 2 2024-04-01 → 2026-05-29 | BOLD Apr avg: 6.25% median: 16.56% win: 67% σ: 32.86% n: 3 2024-04-01 → 2026-05-29 | BOLD May avg: -15.35% median: -7.88% win: 0% σ: 19.51% n: 3 2024-04-01 → 2026-05-29 | BOLD Jun avg: -32.87% median: -32.87% win: 0% σ: 34.92% n: 2 2024-04-01 → 2026-05-29 (current) | BOLD Jul avg: 8.40% median: 8.40% win: 50% σ: 12.62% n: 2 2024-04-01 → 2026-05-29 | BOLD Aug avg: -5.73% median: -5.73% win: 0% σ: 0.35% n: 2 2024-04-01 → 2026-05-29 | BOLD Sep avg: 2.84% median: 2.84% win: 50% σ: 9.88% n: 2 2024-04-01 → 2026-05-29 | BOLD Oct avg: -1.01% median: -1.01% win: 50% σ: 20.98% n: 2 2024-04-01 → 2026-05-29 | BOLD Nov avg: -11.47% median: -11.47% win: 0% σ: 7.02% n: 2 2024-04-01 → 2026-05-29 | BOLD Dec avg: 4.40% median: 4.40% win: 100% σ: 2.59% n: 2 2024-04-01 → 2026-05-29 |